Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$112K Buy
177,297
+82,786
+88% +$62.3K ﹤0.01% 4047
2025
Q4
$83K Buy
94,511
+67,216
+246% +$71.8K ﹤0.01% 4066
2025
Q3
$37.1K Sell
27,295
-167,299
-86% -$253K ﹤0.01% 4252
2025
Q2
$306K Sell
194,594
-16,790
-8% -$31.3K ﹤0.01% 3673
2025
Q1
$558K Buy
211,384
+145,124
+219% +$582K ﹤0.01% 3193
2024
Q4
$281K Buy
66,260
+26,221
+65% +$101K ﹤0.01% 4203
2024
Q3
$133K Sell
40,039
-184,158
-82% -$626K ﹤0.01% 3805
2024
Q2
$693K Buy
224,197
+68,264
+44% +$225K ﹤0.01% 2829
2024
Q1
$630K Buy
155,933
+5,958
+4% +$22.5K ﹤0.01% 2886
2023
Q4
$838K Sell
149,975
-252,620
-63% -$1.45M ﹤0.01% 2643
2023
Q3
$2.15M Buy
402,595
+263,434
+189% +$2.14M 0.01% 1766
2023
Q2
$1.3M Buy
139,161
+95,812
+221% +$841K ﹤0.01% 1967
2023
Q1
$375K Buy
43,349
+31,997
+282% +$282K ﹤0.01% 2455
2022
Q4
$80.3K Sell
11,352
-5,318
-32% -$44.6K ﹤0.01% 2991
2022
Q3
$165K Buy
+16,670
New +$151K ﹤0.01% 2725
2022
Q2
Sell
-110,322
Closed -$1.02M 2970
2022
Q1
$1.02M Buy
+110,322
New +$831K ﹤0.01% 1578

Other funds holding DCGO

Squarepoint's DCGO Position: Q1 2026 in Review

Squarepoint increased its DocGo (DCGO) stake by 88% in Q1 2026, buying an estimated $62.3K and bringing the position to 177,297 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #4047.

Squarepoint first reported a position in DCGO in Q1 2022 and has held it in 16 quarters since. The position peaked at $2.15M in Q3 2023. 122 funds tracked by Wall St. Rank hold DCGO as of Q1 2026.

  • Squarepoint held 177,297 shares of DocGo worth $112K as of Q1 2026.
  • Squarepoint bought 82,786 DocGo shares in Q1 2026, an estimated $62.3K.
  • DocGo made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #4047 holding.
  • Squarepoint first reported a position in DocGo in Q1 2022 and has held it in 16 quarters since.
  • Squarepoint's DocGo position peaked at $2.15M in Q3 2023.
  • 122 funds tracked by Wall St. Rank held DocGo as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.